New methylphenidate transdermal patch for Attention Deficit of Hyperactivity Disorder (ADHD)
In October, we join to the awareness campaigns on ADHD by sharing this article that briefly describes the characteristics of transdermal system containing methylphenidate that has been recently developed by Amarin Technologies for the treatment of this condition.
The times of the industry
The arrival of a drug on the market has many challenges.
Novartis’ Ballet
Exelon® should be featured in pharmaceutical marketing courses as one of the best success stories when it comes to life cycle management. In the following article, we tell the reasons
Big data and pharma
The use of new tools to explore Big Data sets has accelerated their use in the field of health.
AMARIN, the double challenge.
Amarin faces the double challenge of the complexities of the Pharmaceutical Industry, in addition to the unfavorable scenario in macroeconomic terms in Argentina.
Inequality in access to vaccines
Vaccines are one of the health measures that have produced and continue to produce the greatest benefit to humanity, they prevent diseases that previously caused major epidemics, deaths and sequelae.
API characteristics for Transdermal Drug Delivery Systems
In order for an IFA to be administered through the skin, it must meet certain characteristics.
Oral Thin Film(OTF)
An oral thin film (OTF) is a very thin film made up of a single or multilayer polymeric matrix applied in the mouth.
Challenge of transdermal patches
The skin is an accessible and convenient way to administer medications But it has certain limitations.
Introduction to Microneedles
In May 1971, Alza Corporation filed the first patent for a transdermal device that would be the forerunner of what we know today as microneedling.